COVID-19 promotes endothelial dysfunction and thrombogenicity: role of proinflammatory cytokines/SGLT2 prooxidant pathway
Journal of Thrombosis and Haemostasis · 2024-01 · 22 (1) · 286-299
DOI: 10.1016/j.jtha.2023.09.022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024-01. Verfasst von Ali Mroueh und 20 weiteren Autor:innen. Beteiligte Einrichtung: INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France. Hauptthemen laut MEDLINE: COVID-19, Vascular Diseases. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: COVID-19 is associated with an increased risk of cardiovascular complications. Although cytokines have a predominant role in endothelium damage, the precise molecular mechanisms are far from being elucidated. OBJECTIVES: The present study hypothesized that inflammation in patients with COVID-19 contributes to endothelial dysfunction through redox-sensitive SGLT2 overexpression and investigated the protective effect of SGLT2 inhibition by empagliflozin. METHODS: Human plasma samples were collected from patients with acute, subacute, and long COVID-19 (n = 100), patients with non-COVID-19 and cardiovascular risk factors (n = 50), and healthy volunteers (n = 25). Porcine coronary artery endothelial cells (ECs) were incubated with plasma (10%). Protein expression levels were determined using Western blot analyses and immunofluorescence staining, mRNA expression by quantitative reverse transcription-polymerase chain reaction, and the level of oxidative stress by dihydroethidium staining. Platelet adhesion, aggregation, and thrombin generation were determined. RESULTS: Increased plasma levels of interleukin (IL)-1β, IL-6, tumor necrosis factor-α, monocyte chemoattractant protein-1, and soluble intercellular adhesion molecule-1 were observed in patients with COVID-19. Exposure of ECs to COVID-19 plasma with high cytokines levels induced redox-sensitive upregulation of SGLT2 expression via proinflammatory cytokines IL-1β, IL-6, and tumor necrosis factor-α which, in turn, fueled endothelial dysfunction, senescence, NF-κB activation, inflammation, platelet adhesion and aggregation, von Willebrand factor secretion, and thrombin generation. The stimulatory effect of COVID-19 plasma was blunted by neutralizing antibodies against proinflammatory cytokines and empagliflozin. CONCLUSION: In patients with COVID-19, proinflammatory cytokines induced a redox-sensitive upregulation of SGLT2 expression in ECs, which in turn promoted endothelial injury, senescence, platelet adhesion, aggregation, and thrombin generation. SGLT2 inhibition with empagliflozin appeared as an attractive strategy to restore vascular homeostasis in COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France.
- Division of Cardiovascular Medicine, Strasbourg University Hospital, Strasbourg, France.
- INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France; Division of Cardiovascular Medicine, Strasbourg University Hospital, Strasbourg, France.…
- INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France; Division of Cardiovascular Medicine, Strasbourg University Hospital, Strasbourg, France.
- Department Laboratory Haematology, Centre for Thrombosis and Haemostasis, Strasbourg University Hospital, Strasbourg, France.
- Department of Critical Care, Strasbourg University Hospital, Strasbourg, France.
Zitieren
APA
Mroueh, A., Fakih, W., Carmona, A., Trimaille, A., Matsushita, K., Marchandot, B., Qureshi, A. W., Gong, D. S., Auger, C., Sattler, L., Reydel, A., Hess, S., Oulehri, W., Vollmer, O., Lessinger, J. M., Meyer, N., Pieper, M. P., Jesel, L., Bäck, M., …, & Morel, O. (2024). COVID-19 promotes endothelial dysfunction and thrombogenicity: role of proinflammatory cytokines/SGLT2 prooxidant pathway. Journal of Thrombosis and Haemostasis, 22(1), 286-299. https://doi.org/10.1016/j.jtha.2023.09.022
Vancouver
Mroueh A, Fakih W, Carmona A, Trimaille A, Matsushita K, Marchandot B, et al. COVID-19 promotes endothelial dysfunction and thrombogenicity: role of proinflammatory cytokines/SGLT2 prooxidant pathway. Journal of Thrombosis and Haemostasis. 2024;22(1):286-299. doi:10.1016/j.jtha.2023.09.022
BibTeX
@article{Mroueh2024,
author = {Mroueh, Ali and Fakih, Walaa and Carmona, Adrien and Trimaille, Antonin and Matsushita, Kensuke and Marchandot, Benjamin and Qureshi, Abdul Wahid and Gong, Dal-Seong and Auger, Cyril and Sattler, Laurent and Reydel, Antje and Hess, Sébastien and Oulehri, Walid and Vollmer, Olivier and Lessinger, Jean-Marc and Meyer, Nicolas and Pieper, Michael Paul and Jesel, Laurence and Bäck, Magnus and Schini-Kerth, Valérie and Morel, Olivier},
title = {COVID-19 promotes endothelial dysfunction and thrombogenicity: role of proinflammatory cytokines/SGLT2 prooxidant pathway},
journal = {Journal of Thrombosis and Haemostasis},
year = {2024},
volume = {22},
number = {1},
pages = {286--299},
doi = {10.1016/j.jtha.2023.09.022}
}
EUVIMED